Food and Drug Administration Science Forum 2015; Public Workshop, 19087-19088 [2015-08156]

Download as PDF Rmajette on DSK2VPTVN1PROD with NOTICES Federal Register / Vol. 80, No. 68 / Thursday, April 9, 2015 / Notices of about 60 hours per year (5,400 hours total); and 1,230 importers of furs and fur products incur an average recordkeeping burden of 30 hours per year (36,900 hours total)] Disclosure: 185,101 hours [(107,585 hours for labeling + 28,316 hours for invoices + 49,200 hours for advertising).] Estimated annual cost burden: $4,658,000, rounded to the nearest thousand (solely relating to labor costs). Request for Comments You can file a comment online or on paper. For the Commission to consider your comment, we must receive it on or before May 11, 2015. Write ‘‘Fur Rules: FTC File No. P074201’’ on your comment. Your comment—including your name and your state—will be placed on the public record of this proceeding, including, to the extent practicable, on the public Commission Web site, at https://www.ftc.gov/os/ publiccomments.shtm. As a matter of discretion, the Commission tries to remove individuals’ home contact information from comments before placing them on the Commission Web site. Because your comment will be made public, you are solely responsible for making sure that your comment does not include any sensitive personal information, such as anyone’s Social Security number, date of birth, driver’s license number or other state identification number or foreign country equivalent, passport number, financial account number, or credit or debit card number. You are also solely responsible for making sure that your comment does not include any sensitive health information, like medical records or other individually identifiable health information. In addition, do not include any ‘‘[t]rade secret or any commercial or financial information which is . . . privileged or confidential,’’ as discussed in Section 6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2). In particular, do not include competitively sensitive information such as costs, sales statistics, inventories, formulas, patterns, devices, manufacturing processes, or customer names. If you want the Commission to give your comment confidential treatment, you must file it in paper form, with a request for confidential treatment, and you are required to follow the procedure explained in FTC Rule 4.9(c), 16 CFR 4.9(c). Your comment will be kept confidential only if the FTC General Counsel grants your request in accordance with the law and the public interest. VerDate Sep<11>2014 15:13 Apr 08, 2015 Jkt 235001 Postal mail addressed to the Commission is subject to delay due to heightened security screening. As a result, we encourage you to submit your comment online, or to send it to the Commission by courier or overnight service. To make sure that the Commission considers your online comment, you must file it at https:// ftcpublic.commentworks.com/ftc/ furrulespra2, by following the instructions on the web-based form. If this Notice appears at https:// www.regulations.gov, you also may file a comment through that Web site. If you file your comment on paper, write ‘‘Fur Rules: FTC File No. P074201’’ on your comment and on the envelope, and mail or deliver it to the following address: Federal Trade Commission, Office of the Secretary, 600 Pennsylvania Avenue NW., Suite CC–5610 (Annex J), Washington, DC 20580, or deliver your comment to the following address: Federal Trade Commission, Office of the Secretary, Constitution Center, 400 7th Street SW., 5th Floor, Suite 5610 (Annex J), Washington, DC 20024. If possible, submit your paper comment to the Commission by courier or overnight service. The FTC Act and other laws that the Commission administers permit the collection of public comments to consider and use in this proceeding as appropriate. The Commission will consider all timely and responsive public comments that it receives on or before May 11, 2015. You can find more information, including routine uses permitted by the Privacy Act, in the Commission’s privacy policy, at https:// www.ftc.gov/ftc/privacy.shtm. Comments on the information collection requirements subject to review under the PRA should also be submitted to OMB. If sent by U.S. mail, address comments to: Office of Information and Regulatory Affairs, Office of Management and Budget, Attention: Desk Officer for the Federal Trade Commission, New Executive Office Building, Docket Library, Room 10102, 725 17th Street NW., Washington, DC 20503. Comments sent to OMB by U.S. postal mail, however, are subject to delays due to heightened security precautions. Thus, comments instead should be sent by facsimile to (202) 395–5167. David C. Shonka, Principal Deputy General Counsel. [FR Doc. 2015–08151 Filed 4–8–15; 8:45 am] BILLING CODE 6750–01–P PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 19087 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–15–15IG] Agency Forms Undergoing Paperwork Reduction Act Review; Withdrawal Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice withdrawal. AGENCY: Due to an information collection request oversight, the Centers for Disease Control and Prevention (CDC) requests immediate publication withdrawal of the 30-Day Federal Register Notice (FRN) entitled ‘‘Agency Forms Undergoing Paperwork Reduction Act Review’’ concerning the Public Health Associate Program (PHAP) Alumni Assessment. DATES: The 30-day FRN published on March 25, 2015 at 80 FR 15791 is withdrawn as of April 9, 2015. FOR FURTHER INFORMATION CONTACT: For further information call (404) 639–7570 or mail comments to CDC, Leroy A. Richardson, 1600 Clifton Road, MS D– 74, Atlanta, GA 30333 or send an email to omb@cdc.gov. SUMMARY: Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2015–08139 Filed 4–8–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2015–N–0001] Food and Drug Administration Science Forum 2015; Public Workshop AGENCY: Food and Drug Administration, HHS. ACTION: Notice of public workshop. The Food and Drug Administration (FDA) is announcing a public workshop entitled ‘‘FDA Science Forum 2015.’’ The purpose of the public workshop is to highlight science conducted at the FDA by showcasing how scientific research informs regulatory decision making and to provide a forum for developing collaborations within FDA and with external organizations. The focus of the forum will be the eight FDA Regulatory Science priority areas E:\FR\FM\09APN1.SGM 09APN1 19088 Federal Register / Vol. 80, No. 68 / Thursday, April 9, 2015 / Notices (https://www.fda.gov/ScienceResearch/ SpecialTopics/RegulatoryScience/ ucm267719.htm). Date and Time: The public workshop will be held on May 27, 2015, from 8:30 a.m. to 3:45 p.m. and May 28, 2015, from 8:30 a.m. to 4 p.m. Location: The public workshop will be held at FDA White Oak Campus, 10903 New Hampshire Ave., Building 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD 20993– 0002. Entrance for the public workshop participants (non-FDA employees) is through Building 1 where routine security check procedures will be performed. For parking and security information, please refer to https:// www.fda.gov/AboutFDA/ WorkingatFDA/BuildingsandFacilities/ WhiteOakCampusInformation/ ucm241740.htm. Contact Person: Leslie Wheelock, Office of Scientific Professional Development, Office of the Chief Scientist, Office of the Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 1, Rm. 4345, Silver Spring, MD, 301–796–4580, FAX: 301–847–8106, email: FDASciProDev@fda.hhs.gov. Registration: Submit your online registration information (including name, title, firm name, address, telephone and email) by May 15, 2015 at: https://www.fda.gov/scienceresearch/ aboutscienceresearchatfda/ ucm429403.htm. There is no registration fee for the public workshop. Early registration is recommended because seating is limited. There will be no onsite registration. If you need special accommodations due to a disability, please contact Leslie Wheelock (see Contact Person) at least 7 days in advance. Webcast: Please be advised that as soon as possible after the Forum, a webcast and report of the public workshop will be accessible at: https:// www.fda.gov/scienceresearch/ aboutscienceresearchatfda/ ucm429403.htm. Each session of the FDA Science Forum will have an expert in the area and presentations by FDA staff. Rmajette on DSK2VPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: Dated: April 3, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–08156 Filed 4–8–15; 8:45 am] BILLING CODE 4164–01–P VerDate Sep<11>2014 15:13 Apr 08, 2015 Jkt 235001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c) (4) and 552b(c) (6), title 5 U.S.C., as amended. The grant applications/ contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; Outstanding Investigator Award 1. Date: April 29, 2015. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 6W030, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Michael B. Small, Ph.D., Chief, Program and Review Extramural Staff Training Office, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W522, Bethesda, MD 20892, 240–276–6438, smallm@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Targeted Radionuclide Therapy. Date: May 4, 2015. Time: 10:00 a.m. to 6:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W030, Rockville, MD 20850, (Telephone Conference Call). Contact Person: Thomas M. Vollberg, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W102, Rockville, MD 20850, 240–276–6341, vollbert@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI R01 Review. Date: May 21, 2015. Time: 1:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W126, Rockville, MD 20850, (Telephone Conference Call). PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 Contact Person: Caron A. Lyman, Ph.D., Chief, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W126, Bethesda, MD 20892–9750, 240–276–6348, lymanc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI SPORE Review. Date: June 8–9, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Caterina Bianco, MD, Ph.D., Scientific Review Officer, Research Program Review Branch, Division Of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W116, Bethesda, MD 20892–9750, 240–276–6459, biancoc@mail.nih.gov. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/sep/sep.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: April 3, 2015. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–08131 Filed 4–8–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which E:\FR\FM\09APN1.SGM 09APN1

Agencies

[Federal Register Volume 80, Number 68 (Thursday, April 9, 2015)]
[Notices]
[Pages 19087-19088]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-08156]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-N-0001]


Food and Drug Administration Science Forum 2015; Public Workshop

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public workshop.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing a public 
workshop entitled ``FDA Science Forum 2015.'' The purpose of the public 
workshop is to highlight science conducted at the FDA by showcasing how 
scientific research informs regulatory decision making and to provide a 
forum for developing collaborations within FDA and with external 
organizations. The focus of the forum will be the eight FDA Regulatory 
Science priority areas

[[Page 19088]]

(https://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm267719.htm).
    Date and Time: The public workshop will be held on May 27, 2015, 
from 8:30 a.m. to 3:45 p.m. and May 28, 2015, from 8:30 a.m. to 4 p.m.
    Location: The public workshop will be held at FDA White Oak Campus, 
10903 New Hampshire Ave., Building 31 Conference Center, the Great Room 
(Rm. 1503), Silver Spring, MD 20993-0002. Entrance for the public 
workshop participants (non-FDA employees) is through Building 1 where 
routine security check procedures will be performed. For parking and 
security information, please refer to https://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm241740.htm.
    Contact Person: Leslie Wheelock, Office of Scientific Professional 
Development, Office of the Chief Scientist, Office of the Commissioner, 
Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 1, Rm. 
4345, Silver Spring, MD, 301-796-4580, FAX: 301-847-8106, email: 
FDASciProDev@fda.hhs.gov.
    Registration: Submit your online registration information 
(including name, title, firm name, address, telephone and email) by May 
15, 2015 at: https://www.fda.gov/scienceresearch/aboutscienceresearchatfda/ucm429403.htm.
    There is no registration fee for the public workshop. Early 
registration is recommended because seating is limited. There will be 
no onsite registration.
    If you need special accommodations due to a disability, please 
contact Leslie Wheelock (see Contact Person) at least 7 days in 
advance.
    Webcast: Please be advised that as soon as possible after the 
Forum, a webcast and report of the public workshop will be accessible 
at: https://www.fda.gov/scienceresearch/aboutscienceresearchatfda/ucm429403.htm.

SUPPLEMENTARY INFORMATION: Each session of the FDA Science Forum will 
have an expert in the area and presentations by FDA staff.

    Dated: April 3, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-08156 Filed 4-8-15; 8:45 am]
 BILLING CODE 4164-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.